Cargando…
Guanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer
Guanylate-binding protein 1 (GBP1) is known as an interferon-γ-induced GTPase. Here, we used genetically modified ovarian cancer (OC) cells to study the role of GBP1. The data generated show that GBP1 inhibition constrains the clonogenic potential of cancer cells. In vivo studies revealed that GBP1...
Autores principales: | Tailor, Dhanir, Garcia-Marques, Fernando Jose, Bermudez, Abel, Pitteri, Sharon J., Malhotra, Sanjay V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665831/ https://www.ncbi.nlm.nih.gov/pubmed/38026225 http://dx.doi.org/10.1016/j.isci.2023.108292 |
Ejemplares similares
-
Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer
por: Honkala, Alexander T., et al.
Publicado: (2020) -
Integrative modeling of guanylate binding protein dimers
por: Schumann, Wibke, et al.
Publicado: (2023) -
Dynamic Association of Proteasomal Machinery with the Centrosome
por: Christian Wigley, W., et al.
Publicado: (1999) -
Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19
por: Jaiswal, Sarita Rani, et al.
Publicado: (2022) -
A Rapidly Evolving Polybasic Motif Modulates Bacterial Detection by Guanylate Binding Proteins
por: Kohler, Kristin M., et al.
Publicado: (2020)